RecruitingNot ApplicableNCT06904703

Pericapsular Nerve Group and Lumbar Erector Spinae Plane Blocks for Geriatrics Undergoing Total Hip Arthroplasty

Combination of Pericapsular Nerve Group and Lumbar Erector Spinae Plane Blocks for Geriatrics Undergoing Total Hip Arthroplasty Under General Anesthesia: A Randomized Controlled Trial


Sponsor

Tanta University

Enrollment

120 participants

Start Date

Dec 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will be conducted to evaluate the effect of pericapsular nerve group and erector spinae plane block as adjuvants to general anesthesia in geriatrics undergoing total hip arthroplasty.


Eligibility

Min Age: 75 Years

Inclusion Criteria4

  • Aged \>75 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) classification I-III.
  • Undergoing total hip arthroplasty under general anesthesia.

Exclusion Criteria6

  • Patient refusal.
  • Body mass index (BMI) \> 30 kg/m2.
  • Allergy to local anesthesia drugs.
  • Infection at the site of intervention.
  • Coagulopathies.
  • Preexisting advanced diseases of the kidney or liver.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGeneral anesthesia

Patients will receive general anesthesia.

DRUGBupivacaine 0.5%

Patients will receive general anesthesia and erector spinae plane block.

DRUGBupivacaine 0.5%

Patients will receive general anesthesia and erector spinae plane block with pericapsular nerve block.


Locations(1)

Faculty of Medicine

Tanta, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06904703


Related Trials